Tempus AI to Buy Cancer-Tech Firm Personalis For $1.7 Billion

Tempus AI Inc., a technology company developing artificial intelligence for the healthcare industry, has agreed to buy Personalis Inc., a fellow biotech company focused on cancer testing.Read More